Alexander de Leeuw joined Brinkhof as a lawyer in 2015. He specializes in national and international patent litigation with a special focus on pharmaceutical inventions, medical devices and consumer goods. He also regularly deals with and teaches about the protection of know-how/trade secrets and evidentiary seizures.

Since joining Brinkhof, Alexander has gained significant experience litigating in complex patent cases before the Courts in The Hague and the European Patent Office. Some examples of cases that Alexander handled concern CRISPR-Cas9, pemetrexed, lithography machines, optical (laser) systems for surgical use, lateral flow immunoassays and medical catheters.

Next to his litigation practice Alexander enjoys writing about patent law and more particularly publishes about the developments regarding software patents and artificial intelligence (co-author of Software Patents Worldwide and multiple AIPPI Questionnaires). Alexander is also an active member of AIPPI, Young EPLAW, LES, and DNA-editing association ARRIGE.

Alexander has studied law in Amsterdam (University of Amsterdam), New York (Benjamin N. Cardozo School of Law, Yeshiva University) and Copenhagen (University of Copenhagen). His thesis was awarded with one of three prestigious annual awards for best thesis of the University of Amsterdam. Alexander was admitted to the bar in 2015.